Differential effects of phorbol esters on normal myeloid precursors and leukemic cells: basis for autologous bone marrow reconstitution in acute nonlymphocytic leukemia using phorbol ester-treated bone marrow from patients in remission.

Abrahm, J L; Gerson, S L; Hoxie, J A; Tannenbaum, S H; Cassileth, P A; Cooper, R A

Abrahm, J L; Gerson, S L; Hoxie, J A; Tannenbaum, S H; Cassileth, P A; Cooper, R A.

Cancer Res ; 46(7): 3711-6, 1986 Jul.

Article in En | MEDLINE | ID: mdl-3518922

Subject(s)

Bone Marrow Transplantation; Leukemia/therapy; Phorbols/pharmacology; Tetradecanoylphorbol Acetate/pharmacology; Bone Marrow/drug effects; Bone Marrow Cells; Cell Cycle/drug effects; Cell Differentiation/drug effects; Cells, Cultured; Colony-Forming Units Assay; Combined Modality Therapy; Dose-Response Relationship, Drug; Freezing; Hematopoiesis/drug effects; Humans; Karyotyping; Leukemia, Myeloid, Acute/pathology; Preservation, Biological; Tetradecanoylphorbol Acetate/therapeutic use; Time Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Phorbols / Tetradecanoylphorbol Acetate / Leukemia / Bone Marrow Transplantation Limits: Humans Language: En Journal: Cancer Res Year: 1986 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links